186 related articles for article (PubMed ID: 31038586)
1. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
2. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
3. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
[TBL] [Abstract][Full Text] [Related]
8. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
Sun Q; Li F; Sun F; Niu J
Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
[TBL] [Abstract][Full Text] [Related]
10. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
Ye XW; Hu HJ; Xiong XZ; Lu J; Cheng NS
Surg Today; 2021 Aug; 51(8):1352-1360. PubMed ID: 33651221
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
14. Combined vascular resection and analysis of prognostic factors for hilar cholangiocarcinoma.
Wang ST; Shen SL; Peng BG; Hua YP; Chen B; Kuang M; Li SQ; He Q; Liang LJ
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):626-32. PubMed ID: 26663011
[TBL] [Abstract][Full Text] [Related]
15. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
16. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines.
Chen YJ; Xiong XF; Wen SQ; Tian L; Cheng WL; Qi YQ
Genet Mol Res; 2015 Jun; 14(2):7053-61. PubMed ID: 26125915
[TBL] [Abstract][Full Text] [Related]
18. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.
Bhutiani N; Scoggins CR; McMasters KM; Ethun CG; Poultsides GA; Pawlik TM; Weber SM; Schmidt CR; Fields RC; Idrees K; Hatzaras I; Shen P; Maithel SK; Martin RCG
Surgery; 2018 Apr; 163(4):726-731. PubMed ID: 29306541
[TBL] [Abstract][Full Text] [Related]
19. Surgical procedure and prognosis of hilar cholangiocarcinoma.
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
[TBL] [Abstract][Full Text] [Related]
20. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management].
Kovalenko YA; Vishnevsky VA; Chzhao AV; Zharikov YO
Khirurgiia (Mosk); 2018; (8):4-11. PubMed ID: 30113586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]